252 related articles for article (PubMed ID: 5121700)
21. 5-fluorouracil (5-FU) ointment in the treatment of benign and malignant skin lesions.
Midana A; Leigheb G
Dermatologica; 1970; 140():Suppl 1:75-81. PubMed ID: 5471366
[No Abstract] [Full Text] [Related]
22. [Comparative topic treatments of basal cell carcinomas and senile keratoses with 5-FU, retinoic acid and DNCB sensitization (author's transl)].
Remy W; Stüttgen G
Dermatologica; 1974; 148(2):72-81. PubMed ID: 4134912
[No Abstract] [Full Text] [Related]
23. [Experiences with a cytostaticly active ointment in the dermatologic practice. (5 per cent--5-fluorouracil ointment)].
Weitgasser H
Wien Med Wochenschr; 1969 Mar; 119(13):253-5. PubMed ID: 5767544
[No Abstract] [Full Text] [Related]
24. Treatment of skin cancers and keratoses with 5-fluorouracil.
Snyderman RK; Starzynski TE
Acta Chir Plast; 1968; 10(3):181-7. PubMed ID: 4179806
[No Abstract] [Full Text] [Related]
25. [Experience on topical 5-fluoruracil- (5-FU) in cutaneous carcinomatosis. I. Test on the efficiency of topical 5-FU].
Chiaffitelli C; Suarez Halty L
An Fac Med Univ Repub Montev Urug; 1966; 51(1):30-9. PubMed ID: 6015088
[No Abstract] [Full Text] [Related]
26. The treatment of premalignant and malignant skin lesions with 5-fluorouracil.
Farah FS; Shbaklo Z
J Med Liban; 1971; 24(1):45-51. PubMed ID: 4253050
[No Abstract] [Full Text] [Related]
27. Tendency of fluorouracil to conceal deep foci of invasive basal cell carcinoma.
Mohs FE; Jones DL; Bloom RF
Arch Dermatol; 1978 Jul; 114(7):1021-2. PubMed ID: 686718
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of basal cell epithelioma of the skin with topical 5-fluorouracil].
Lukowska I
Przegl Dermatol; 1974; 61(2):201-4. PubMed ID: 4832864
[No Abstract] [Full Text] [Related]
29. Preliminary studies in the use of 5-fluoro-uracil cream in the treatment of malignant and premalignant skin tumours.
Anderson FE; Johnson AM; Havyatt MT
Med J Aust; 1969 Aug; 2(8):385-8. PubMed ID: 5821141
[No Abstract] [Full Text] [Related]
30. Topical use of 5-fluorouracil.
Johnson A
Med J Aust; 1973 Jun; 1(23):1164. PubMed ID: 4725451
[No Abstract] [Full Text] [Related]
31. Proceedings: Use of 5 fluorouracil in the topical therapy of skin cancer: a review of 157 patients.
Litwin MS; Ryan RF; Ichinose H; Reed RR; Kremetz ET
Proc Natl Cancer Conf; 1972; 7():549-61. PubMed ID: 4764922
[No Abstract] [Full Text] [Related]
32. Possibilities and limits of topical 5-fluorouracil treatment in precancerous and cancerous skin lesions.
Leigheb G; Mazzocchi S; Pippione M
Panminerva Med; 1975; 17(7-8):265-6. PubMed ID: 1161333
[No Abstract] [Full Text] [Related]
33. [Therapeutic trial with 5-fluorouracil ointment].
Lopes CF; Armond S
Hospital (Rio J); 1970 Apr; 77(4):1275-80. PubMed ID: 4939510
[No Abstract] [Full Text] [Related]
34. Topical chemotherapy of basal and squamous skin cancers with 5-fluorouracil cream.
Litwin MS; Krementz ET
Panminerva Med; 1974 Mar; 16(3):84-5. PubMed ID: 4449647
[No Abstract] [Full Text] [Related]
35. Nodular superficial pigmented basal cell epitheliomas.
Shelley WB; Wood MG
Arch Dermatol; 1982 Nov; 118(11):928-30. PubMed ID: 7138053
[TBL] [Abstract][Full Text] [Related]
36. Topical 5-fluorouracil: variability of effective dosage and duration of reaction.
Sykes MP; Salem P; Joffe B
J Am Geriatr Soc; 1971 Dec; 19(12):977-82. PubMed ID: 5153692
[No Abstract] [Full Text] [Related]
37. Topical fluorouracil (5-FU) for premalignant keratoses.
Med Lett Drugs Ther; 1971 May; 13(11):45-6. PubMed ID: 5164045
[No Abstract] [Full Text] [Related]
38. [Topical cytostatic treatment of epitheliomas with a 5 per cent 5-fluorouracil ointment].
Ebner H
Z Haut Geschlechtskr; 1968 Sep; 43(18):757-62. PubMed ID: 5715906
[No Abstract] [Full Text] [Related]
39. [2 years' experience with local treatment by 5-fluorouracil].
Bouillenne JC
Arch Belg Dermatol Syphiligr; 1970; 26(1):33-7. PubMed ID: 5519041
[No Abstract] [Full Text] [Related]
40. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy.
Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C
Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
